Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure - the COVID PLEX+CCP Trial

NCT04634422 is registered in ClinicalTrials.gov with Wladimir Szpirt as lead sponsor.

NCT NCT04634422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure - the COVID PLEX+CCP Trial
Lead sponsor
Wladimir Szpirt
Phase
Not applicable
Overall status
Unknown status
Start date
November 16, 2020
Completion date
June 30, 2022
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure, acute, respiratory failure